REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy

Investigator: Polly Niravath, MD

Study Coordinator: Alexys Brock

Status: Enrolling Number: NCT01984138

Phone: 346.238.4814

Protocol Number: Pro00017710


This study is investigating whether breast cancer patients who experience vaginal dryness while on anti-estrogen treatment could benefit from either vaginal estrogen or from a vaginal moisturizer called Replens.
More to Explore